Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Austar Lifesciences Ltd. ( (HK:6118) ) just unveiled an announcement.
Austar Lifesciences Limited has announced that its board of directors will hold a meeting on March 26, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. The board will also consider recommending a final dividend payment, which could impact the company’s financial strategy and shareholder returns.
More about Austar Lifesciences Ltd.
Austar Lifesciences Limited is a company incorporated in the Cayman Islands, operating within the life sciences industry. It is listed on the Hong Kong Stock Exchange and focuses on providing products and services related to life sciences.
YTD Price Performance: 50.88%
Average Trading Volume: 152,160
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$425.4M
Learn more about 6118 stock on TipRanks’ Stock Analysis page.